LTF and neoplasm: Lactoferrin demonstrates high affinity to its receptors overexpressed on cancer cells, which facilitates a great potential of lactoferrin nanoparticles for active targeting of tumor and overcoming such physiological barriers as the gastrointestinal barrier and blood–brain barrier.